LifeStance Health Group, Inc. (LFST)
NASDAQ (NGS) NASDAQ (NGS) Primary 
LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
High oil prices and market volatility spotlight five low-leverage stocks with strong earnings growth and resilient balance sheets.
LifeStance Health (LFST) Upgraded to Buy: Here's Why
LifeStance Health (LFST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out?
LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LifeStance Health Group Q2 Earnings Call Highlights
LifeStance Health Group NASDAQ: LFST reported second-quarter results that exceeded its prior expectations, driven by higher visit volumes, increased revenue per visit and continued clinician productivity gains. The outpatient mental health provider raised its full-year revenue, Center Margin and adjusted EBITDA guidance.
LifeStance Health Group, Inc. (LFST) Q2 2026 Earnings Call Transcript
LifeStance Health Group, Inc. (LFST) Q2 2026 Earnings Call Transcript
LifeStance Health Group (LFST) Tops Q2 Earnings and Revenue Estimates
LifeStance Health Group (LFST) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.01 per share a year ago.
Are You Looking for a Top Momentum Pick? Why LifeStance Health Group (LFST) is a Great Choice
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for LifeStance Health (LFST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
